Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousLeukemiaWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLiver TransplantationTransplantation ChimeraLeukemia, Myeloid, AcuteGraft SurvivalTissue DonorsHematopoietic Stem CellsBone Marrow PurgingBusulfanLeukemia, MyeloidHistocompatibility TestingCyclophosphamideHistocompatibilityCombined Modality TherapyLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation, IsogeneicBone Marrow DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisKidney TransplantationRecurrenceTreatment OutcomeMice, Inbred C57BLTime FactorsRadiation ChimeraRemission InductionBone Marrow ExaminationSurvival AnalysisHematologic NeoplasmsAcute DiseaseAntineoplastic Combined Chemotherapy ProtocolsImmunosuppressive AgentsGraft RejectionAntineoplastic AgentsTumor Cells, CulturedBone RemodelingBone Marrow NeoplasmsHepatic Veno-Occlusive DiseaseCell DifferentiationColony-Forming Units AssayRetrospective StudiesFlow CytometryT-LymphocytesKidney NeoplasmsLeukemia, LymphoidGraft vs Host ReactionTransplantation ImmunologyCarcinoma, Renal CellLymphoma, Non-HodgkinImmunosuppressionSurvival RateStem Cell TransplantationLymphocyte DepletionLeukocyte TransfusionApoptosisCytarabinePrognosisHeart TransplantationMyelodysplastic SyndromesFollow-Up StudiesCell ProliferationDisease-Free SurvivalEtoposideCell DivisionCell Line, TumorHLA AntigensChimeraSevere Combined ImmunodeficiencyMice, Inbred BALB CBreast NeoplasmsNeoplasmsAntibodies, MonoclonalLung TransplantationActuarial AnalysisHematologic DiseasesCyclosporineBone DensityCell SurvivalLymphocyte TransfusionCells, CulturedLeukemia, ExperimentalGene Expression Regulation, NeoplasticGranulocytesNuclear FamilyGranulocyte Colony-Stimulating FactorLeukocyte CountGraft vs Leukemia EffectCarmustineLymphoma